These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19806904)

  • 1. [Caenorhabditis elegans: a powerful tool for drug discovery].
    Jia XH; Cao C
    Yao Xue Xue Bao; 2009 Jul; 44(7):687-94. PubMed ID: 19806904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenorhabditis elegans: a versatile platform for drug discovery.
    Artal-Sanz M; de Jong L; Tavernarakis N
    Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine targets for pharmacological intervention in aging in Caenorhabditis elegans.
    Gill MS
    Aging Cell; 2006 Feb; 5(1):23-30. PubMed ID: 16441840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the Krogh Principle in the post-genome era: Caenorhabditis elegans as a model system for integrative physiology research.
    Strange K
    J Exp Biol; 2007 May; 210(Pt 9):1622-31. PubMed ID: 17449828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invertebrate animal models of diseases as screening tools in drug discovery.
    Ségalat L
    ACS Chem Biol; 2007 Apr; 2(4):231-6. PubMed ID: 17455900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R; Merchant KM; Ryan T
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caenorhabditis elegans as a model for innate immunity to pathogens.
    Gravato-Nobre MJ; Hodgkin J
    Cell Microbiol; 2005 Jun; 7(6):741-51. PubMed ID: 15888078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling human diseases in Caenorhabditis elegans.
    Markaki M; Tavernarakis N
    Biotechnol J; 2010 Dec; 5(12):1261-76. PubMed ID: 21154667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic target discovery using Caenorhabditis elegans.
    Link EM; Hardiman G; Sluder AE; Johnson CD; Liu LX
    Pharmacogenomics; 2000 May; 1(2):203-17. PubMed ID: 11256592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery: here comes the worm.
    Ségalat L
    ACS Chem Biol; 2006 Jun; 1(5):277-8. PubMed ID: 17163755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developmental insights from high-throughput biological analysis in Caenorhabditis elegans.
    Labbé JC; Roy R
    Clin Genet; 2006 Apr; 69(4):306-14. PubMed ID: 16630163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and the worm: Caenorhabditis elegans as a platform for integrating chemical and biological research.
    Hulme SE; Whitesides GM
    Angew Chem Int Ed Engl; 2011 May; 50(21):4774-807. PubMed ID: 21500322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The versatile worm: genetic and genomic resources for Caenorhabditis elegans research.
    Antoshechkin I; Sternberg PW
    Nat Rev Genet; 2007 Jul; 8(7):518-32. PubMed ID: 17549065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-apoptotic cell death in Caenorhabditis elegans.
    Vlachos M; Tavernarakis N
    Dev Dyn; 2010 May; 239(5):1337-51. PubMed ID: 20108319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods.
    Giacomotto J; Ségalat L; Carre-Pierrat M; Gieseler K
    Methods; 2012 Jan; 56(1):103-13. PubMed ID: 22041718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C. elegans as a model for human inherited degenerative diseases].
    Ségalat L; Néri C
    Med Sci (Paris); 2003 Dec; 19(12):1218-25. PubMed ID: 14691746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caenorhabditis elegans: nature and nurture gift to nematode parasitologists.
    Salinas G; Risi G
    Parasitology; 2018 Jul; 145(8):979-987. PubMed ID: 29208057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the neural and molecular mechanisms of C. elegans behavior.
    Schafer WR
    Curr Biol; 2005 Sep; 15(17):R723-9. PubMed ID: 16139205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans.
    Burns AR; Kwok TC; Howard A; Houston E; Johanson K; Chan A; Cutler SR; McCourt P; Roy PJ
    Nat Protoc; 2006; 1(4):1906-14. PubMed ID: 17487175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery: Insights from the invertebrate Caenorhabditis elegans.
    Giunti S; Andersen N; Rayes D; De Rosa MJ
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00721. PubMed ID: 33641258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.